Nephros, Inc.
NEPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $4,764 | $4,419 | $4,877 | $3,870 |
| % Growth | 7.8% | -9.4% | 26% | – |
| Cost of Goods Sold | $1,849 | $1,624 | $1,723 | $1,395 |
| Gross Profit | $2,915 | $2,795 | $3,154 | $2,475 |
| % Margin | 61.2% | 63.2% | 64.7% | 64% |
| R&D Expenses | $338 | $311 | $295 | $252 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,229 | $2,201 | $2,254 | $1,872 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $34 | $35 | $39 | $34 |
| Operating Expenses | $2,601 | $2,547 | $2,588 | $2,158 |
| Operating Income | $314 | $248 | $566 | $317 |
| % Margin | 6.6% | 5.6% | 11.6% | 8.2% |
| Other Income/Exp. Net | $26 | -$2 | -$8 | $47 |
| Pre-Tax Income | $340 | $246 | $558 | $364 |
| Tax Expense | $3 | $9 | $0 | $15 |
| Net Income | $337 | $237 | $558 | $349 |
| % Margin | 7.1% | 5.4% | 11.4% | 9% |
| EPS | 0.03 | 0.022 | 0.053 | 0.033 |
| % Growth | 33.9% | -57.4% | 58.9% | – |
| EPS Diluted | 0.03 | 0.022 | 0.053 | 0.033 |
| Weighted Avg Shares Out | 10,612 | 10,600 | 10,600 | 10,544 |
| Weighted Avg Shares Out Dil | 11,041 | 10,813 | 10,616 | 10,556 |
| Supplemental Information | – | – | – | – |
| Interest Income | $41 | $31 | $13 | $28 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $34 | $35 | $40 | $36 |
| EBITDA | $374 | $282 | $598 | $400 |
| % Margin | 7.9% | 6.4% | 12.3% | 10.3% |